[{"address1": "601 Brickell Key Drive", "address2": "Suite 1000", "city": "Miami", "state": "FL", "zip": "33131", "country": "United States", "phone": "305 203 2034", "website": "https://www.smmttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.", "fullTimeEmployees": 159, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert W. Duggan", "age": 80, "title": "Co-CEO & Executive Chairman", "yearBorn": 1944, "fiscalYear": 2024, "totalPay": 158613, "exercisedValue": 0, "unexercisedValue": 1133457}, {"maxAge": 1, "name": "Dr. Mahkam  Zanganeh D.D.S., M.B.A.", "age": 54, "title": "Co-CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1161021, "exercisedValue": 0, "unexercisedValue": 128563160}, {"maxAge": 1, "name": "Prof. Dame Kay Davies DBE, FRS CBE", "age": 73, "title": "Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dave  Gancarz", "title": "Chief Business & Strategy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Fong  Clow", "title": "Chief Biometrics Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shelley D. Spray", "age": 59, "title": "Chief Education & Brand Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Urte  Gayko Ph.D.", "age": 53, "title": "Chief Regulatory, Quality & Pharmacovigilance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Allen S. Yang M.D., Ph.D.", "age": 56, "title": "Chief Medical Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laura Q. M. Chow M.D.", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  LaCaze", "title": "Chief Commercial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 10, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 26.37, "open": 25.86, "dayLow": 25.4107, "dayHigh": 27.44, "regularMarketPreviousClose": 26.37, "regularMarketOpen": 25.86, "regularMarketDayLow": 25.4107, "regularMarketDayHigh": 27.44, "payoutRatio": 0.0, "beta": -1.02, "forwardPE": -71.23684, "volume": 1916480, "regularMarketVolume": 1916480, "averageVolume": 3853479, "averageVolume10days": 2168690, "averageDailyVolume10Day": 2168690, "bid": 25.03, "ask": 28.69, "bidSize": 2, "askSize": 2, "marketCap": 20103968768, "fiftyTwoWeekLow": 8.88, "fiftyTwoWeekHigh": 36.91, "fiftyDayAverage": 23.4738, "twoHundredDayAverage": 21.387924, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 19749101568, "profitMargins": 0.0, "floatShares": 116056404, "sharesOutstanding": 742665984, "sharesShort": 28557957, "sharesShortPriorMonth": 30530476, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0385, "heldPercentInsiders": 0.84319997, "heldPercentInstitutions": 0.13643, "shortRatio": 7.4, "shortPercentOfFloat": 0.2448, "impliedSharesOutstanding": 742665984, "bookValue": 0.464, "priceToBook": 58.34052, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -240755008, "trailingEps": -0.34, "forwardEps": -0.38, "enterpriseToEbitda": -83.908, "52WeekChange": 1.7029455, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 27.07, "targetHighPrice": 43.34183, "targetLowPrice": 11.663747, "targetMeanPrice": 34.115166, "targetMedianPrice": 34.94611, "recommendationMean": 1.45455, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 361315008, "totalCashPerShare": 0.487, "ebitda": -235366000, "totalDebt": 6450000, "quickRatio": 10.36, "currentRatio": 10.63, "debtToEquity": 1.873, "returnOnAssets": -0.525, "returnOnEquity": -1.23928, "freeCashflow": -104799248, "operatingCashflow": -173140000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SMMT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1754092763, "regularMarketTime": 1754078401, "shortName": "Summit Therapeutics Inc.", "longName": "Summit Therapeutics Inc.", "regularMarketChangePercent": 2.65453, "regularMarketPrice": 27.07, "marketState": "CLOSED", "exchange": "NGM", "messageBoardId": "finmb_11611587", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1425565800000, "cryptoTradeable": false, "postMarketChangePercent": 0.8127123, "postMarketPrice": 27.29, "postMarketChange": 0.22000122, "regularMarketChange": 0.699999, "regularMarketDayRange": "25.4107 - 27.44", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3853479, "fiftyTwoWeekLowChange": 18.189999, "fiftyTwoWeekLowChangePercent": 2.0484233, "fiftyTwoWeekRange": "8.88 - 36.91", "fiftyTwoWeekHighChange": -9.84, "fiftyTwoWeekHighChangePercent": -0.2665944, "fiftyTwoWeekChangePercent": 170.29454, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754510400, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.34, "epsForward": -0.38, "epsCurrentYear": -0.29571, "priceEpsCurrentYear": -91.54239, "fiftyDayAverageChange": 3.596199, "fiftyDayAverageChangePercent": 0.15320054, "twoHundredDayAverageChange": 5.6820755, "twoHundredDayAverageChangePercent": 0.26566747, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Summit Therapeutics plc", "nameChangeDate": "2025-07-27", "averageAnalystRating": "1.5 - Strong Buy", "displayName": "Summit Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]